ABSTRACT. Background. Short-course antibiotic regimens, ranging in duration from a single dose to 3 days, are the current standard of care for the treatment of acute lower urinary tract infections (UTIs) in adult women. Despite multiple small randomized, controlled trials (RCTs) showing no difference in efficacy between shortcourse (<3 days) and long-course (7-14 days) therapy in children, concerns about occult pyelonephritis and renal scarring have prompted standard recommendations of 7 to 14 days of antibiotics for UTIs in children.Objective. To determine whether long-course antibiotic therapy is more effective than short-course therapy for the treatment of UTIs in children, and to explore potential sources of heterogeneity in the results of existing studies.Methods. We searched online bibliographic databases (Medline and Cochrane Clinical Trials Registry) for RCTs comparing short-and long-course therapy for the treatment of UTI in children, and examined the references of all retrieved articles. Candidate studies for meta-analysis were restricted to RCTs comparing shortcourse (<3 days) and long-course (7-14 days) outpatient therapy for acute UTI in children age 0 to 18 years. We excluded studies that were restricted to children with recurrent UTI or included children with asymptomatic bacteriuria. Sixteen studies met the inclusion criteria. Study quality was evaluated using a 9-item scoring system developed by the investigators. Data on the primary outcomes-treatment failure and reinfection rate-were extracted when available and reanalyzed based on intention to treat whenever possible. To determine whether anatomic level of infection (upper vs lower urinary tract) influenced the results, the meta-analysis was repeated on the subgroup of studies that attempted to restrict their participants to children with lower UTI. To determine whether there was a dose-response effect for the duration of short-course therapy, we performed separate subgroup analyses of studies of single-dose or single-day therapy and studies of 3-day therapy. To explore other potential sources of study result heterogeneity, such as study quality and patient age, we developed a random-effects regression model that included these variables as covariates.Results. S hort-course antibiotic regimens, ranging in duration from a single dose to 3 days, are the current standard of care for the treatment of uncomplicated lower urinary tract infections (UTIs) in women. 1 In addition to being effective, shorter treatment regimens are less expensive, improve adherence, have fewer side effects, and may prevent reinfections with resistant organisms. 2,3 Despite the proven efficacy and advantages of short-course antibiotic treatment of lower UTI in adults, pediatricians have hesitated to extrapolate this practice to children for several reasons. By the time UTIs are identified in preverbal children, there is often upper tract involvement that cannot be reliably and easily distinguished from lower tract disease by clinical signs and symptoms or laboratory test...